NL185146C - Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd. - Google Patents
Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd.Info
- Publication number
- NL185146C NL185146C NLAANVRAGE8020199,A NL8020199A NL185146C NL 185146 C NL185146 C NL 185146C NL 8020199 A NL8020199 A NL 8020199A NL 185146 C NL185146 C NL 185146C
- Authority
- NL
- Netherlands
- Prior art keywords
- aggregation
- alkoxy group
- inhibitory effect
- pharmaceutical preparation
- derivative substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2565880A JPS56122356A (en) | 1980-02-29 | 1980-02-29 | Carbostyril derivative |
| JP2565880 | 1980-02-29 | ||
| JP8000122 | 1980-06-04 | ||
| PCT/JP1980/000122 WO1981002421A1 (en) | 1980-02-29 | 1980-06-04 | Carbostyryl derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8020199A NL8020199A (nl) | 1981-12-01 |
| NL185146B NL185146B (nl) | 1989-09-01 |
| NL185146C true NL185146C (nl) | 1990-02-01 |
Family
ID=12171902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE8020199,A NL185146C (nl) | 1980-02-29 | 1980-06-04 | Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4435404A (de) |
| JP (1) | JPS56122356A (de) |
| KR (2) | KR860002099B1 (de) |
| AT (1) | AT381493B (de) |
| AU (1) | AU532319B2 (de) |
| BE (1) | BE883713A (de) |
| CA (1) | CA1159068A (de) |
| CH (1) | CH647765A5 (de) |
| DE (1) | DE3049959T1 (de) |
| DK (1) | DK151956C (de) |
| ES (1) | ES492230A0 (de) |
| FI (1) | FI76321C (de) |
| FR (1) | FR2477149A1 (de) |
| GB (1) | GB2070588B (de) |
| IT (1) | IT1129812B (de) |
| MX (1) | MX6752E (de) |
| NL (1) | NL185146C (de) |
| NO (1) | NO160512C (de) |
| PH (1) | PH18532A (de) |
| PT (1) | PT71359B (de) |
| SE (1) | SE461147B (de) |
| SU (2) | SU1169535A3 (de) |
| WO (1) | WO1981002421A1 (de) |
| ZA (1) | ZA803322B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578381A (en) * | 1982-07-05 | 1986-03-25 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
| DE3434271A1 (de) * | 1984-09-19 | 1986-03-20 | Beiersdorf Ag, 2000 Hamburg | Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen |
| JP2753622B2 (ja) * | 1988-05-02 | 1998-05-20 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| US5227381A (en) * | 1988-05-02 | 1993-07-13 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative |
| AU653060B2 (en) * | 1991-08-23 | 1994-09-15 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative and platelet agglutination inhibitor |
| JP2686887B2 (ja) * | 1992-08-11 | 1997-12-08 | キッセイ薬品工業株式会社 | ピペリジノ−３，４−ジヒドロカルボスチリル誘導体 |
| US7208497B2 (en) | 2001-07-02 | 2007-04-24 | Novo Nordisk A/S | Substituted piperazines and diazepanes |
| WO2011021676A1 (ja) | 2009-08-21 | 2011-02-24 | 大塚製薬株式会社 | ベンゾ［ｂ］［１，４］ジアゼピン－２，４－ジオン化合物の製造方法 |
| TWI481601B (zh) * | 2009-08-21 | 2015-04-21 | Otsuka Pharma Co Ltd | 含氮化合物及藥學組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1021522A (en) * | 1963-05-10 | 1966-03-02 | Ici Ltd | 2-quinolone derivatives |
| DE1527937A1 (de) * | 1966-12-10 | 1969-11-13 | Blanc & Co | Verfahren zur Herstellung eines sich konisch verjuengenden,einen nach aussen abgewinkelten flachen Rand aufweisenden Hohlteils sowie Einrichtung zur Durchfuehrung des Verfahrens |
| JPS48103590A (de) * | 1972-04-13 | 1973-12-25 | ||
| JPS5082218A (de) * | 1973-11-10 | 1975-07-03 | ||
| JPS5310988B2 (de) * | 1974-04-25 | 1978-04-18 | ||
| JPS5318030B2 (de) * | 1974-05-20 | 1978-06-13 | ||
| US4313947A (en) | 1974-06-24 | 1982-02-02 | Otsuka Pharmaceutical Co., Ltd. | Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use |
| FI59246C (fi) * | 1974-06-24 | 1981-07-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin |
| US4081447A (en) * | 1975-04-09 | 1978-03-28 | Abbott Laboratories | 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof |
| JPS5273879A (en) * | 1975-12-18 | 1977-06-21 | Otsuka Pharmaceut Co Ltd | Synthesis of ester derivatives |
| JPS545981A (en) * | 1977-06-10 | 1979-01-17 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
| IE46852B1 (en) * | 1977-06-10 | 1983-10-05 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives |
-
1980
- 1980-02-29 JP JP2565880A patent/JPS56122356A/ja active Granted
- 1980-06-04 PH PH24106A patent/PH18532A/en unknown
- 1980-06-04 WO PCT/JP1980/000122 patent/WO1981002421A1/ja active Application Filing
- 1980-06-04 CH CH6674/81A patent/CH647765A5/de not_active IP Right Cessation
- 1980-06-04 NL NLAANVRAGE8020199,A patent/NL185146C/xx not_active IP Right Cessation
- 1980-06-04 DE DE803049959T patent/DE3049959T1/de active Granted
- 1980-06-04 US US06/261,177 patent/US4435404A/en not_active Expired - Fee Related
- 1980-06-04 AU AU59859/80A patent/AU532319B2/en not_active Ceased
- 1980-06-04 AT AT0909480A patent/AT381493B/de not_active IP Right Cessation
- 1980-06-04 ZA ZA00803322A patent/ZA803322B/xx unknown
- 1980-06-05 KR KR1019800002229A patent/KR860002099B1/ko active
- 1980-06-06 CA CA000353541A patent/CA1159068A/en not_active Expired
- 1980-06-06 GB GB8018609A patent/GB2070588B/en not_active Expired
- 1980-06-06 PT PT71359A patent/PT71359B/pt unknown
- 1980-06-06 ES ES492230A patent/ES492230A0/es active Granted
- 1980-06-06 IT IT67888/80A patent/IT1129812B/it active
- 1980-06-06 MX MX808865U patent/MX6752E/es unknown
- 1980-06-09 FI FI801843A patent/FI76321C/fi not_active IP Right Cessation
- 1980-06-09 FR FR8012744A patent/FR2477149A1/fr active Granted
- 1980-06-09 BE BE0/200953A patent/BE883713A/fr not_active IP Right Cessation
-
1981
- 1981-04-29 SE SE8102690A patent/SE461147B/sv not_active IP Right Cessation
- 1981-05-11 SU SU813280901A patent/SU1169535A3/ru active
- 1981-06-09 DK DK250381A patent/DK151956C/da not_active IP Right Cessation
- 1981-10-15 NO NO81813477A patent/NO160512C/no unknown
-
1982
- 1982-06-18 SU SU823456112A patent/SU1395140A3/ru active
-
1984
- 1984-05-29 KR KR1019840002957A patent/KR860002100B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL183888C (nl) | Carbostyrilderivaat met een remmende werking op de aggregatie van bloedplaatjes, werkwijze ter bereiding van deze derivaten, farmaceutisch preparaat dat een dergelijk derivaat bevat en werkwijze ter bereiding van dergelijke farmaceutische preparaten. | |
| NL183358C (nl) | Farmaceutisch preparaat, en daarin te gebruiken penicillaanzuur-derivaat met beta-lactamase-remmende werking. | |
| NL980013I1 (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
| NL184364B (nl) | Carbostyrilderivaten en zouten daarvan, alsmede gevormd farmaceutisch preparaat dat een of meer van dergelijke carbostyrilverbindingen bevat. | |
| NL190664B (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
| ATE59003T1 (de) | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4dihydro-4-oxo-7-(1-piperazinyl)-chinolon-3carbons|ure. | |
| NL190519B (nl) | 4-gesubstitueerde fenylazijnzuurverbindingen, alsmede farmaceutische preparaten. | |
| NL930046I2 (nl) | Gesubstitueerde iminodizuren, hun bereiding en henbevattende farmaceutische mengsels. | |
| NL190554B (nl) | Cefalosporinederivaat, en farmaceutisch of veterinair preparaat met antibacteriele werking, dat dit cefalosporinederivaat bevat. | |
| NL190631B (nl) | Farmaceutisch preparaat met antibacteriele werking dat amoxycilline en een zout van clavulanzuur bevat. | |
| TR17738A (tr) | Triazolil-o,n-asetaller,bunlarin hazirlanmasina mahsus usuller ve bunlarin fungisitler olarak kullanilmasi | |
| NO160303C (no) | Polymeriseringskatalysator, katalysatorbestanddel for fremstilling av katalysatoren og anvendelse av katalysatoren. | |
| NL930061I2 (nl) | Anti-fungus-middelen, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze anti-fungus-middelen bevatten. | |
| NL185146C (nl) | Farmaceutisch preparaat met een remmende werking op een aggregatie van bloedplaatjes, alsmede carbostyrilderivaat, dat met een aminocarbonylalkoxygroep is gesubstitueerd. | |
| NL187912C (nl) | Farmaceutisch preparaat dat een carbostyrilderivaat bevat, alsmede carbostyrilderivaat, gesubstitueerd door een (1-piperidyl)alkoxygroep. | |
| NL169591C (nl) | Werkwijze voor het bereiden van 2-4-(2-furoyl)-piperazine-1-yl-4-amino-6,7-dimethoxychinazoline.hydrochloride met bloeddrukverlagende werking en van een geneesmiddel met bloeddrukverlagende werking dat dit zout bevat. | |
| NL176070C (nl) | Farmaceutisch preparaat met analgetische werking, alsmede ester van 4-(acetylamino)fenol met een aminozuur. | |
| TR18891A (tr) | 1-(2-halojeno-2-fenil-etil)-triazoller,bunlarin hazirlanisina ait usul ve bunlarin fungisidler olarak kullanilmalar | |
| NL189258C (nl) | Zout van 3-isobutoxy-2-pyrrolidino-n-fenyl-n-benzyl-propylamine met cardiovasculaire eigenschappen, alsmede geneesmiddel dat dit zout bevat. | |
| NL7903769A (nl) | Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan. | |
| NL185923C (nl) | Farmaceutisch preparaat met antibacteriele werking, alsmede penam-3-carbonzuur-1,1-dioxyde-derivaat. | |
| DD134036A5 (de) | Pestizide mittel | |
| DK148875C (da) | Blodfilterelement, isaer til brug ved blodtransfusioner | |
| DZ276A1 (fr) | Préparations pharmaceutiques. | |
| NL7807679A (nl) | Nieuwe benzamidinederivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten, die hen bevatten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| V1 | Lapsed because of non-payment of the annual fee |